Depression fighter Cymbalta still is gobbling up market share. Diabetes drug Humalog has turned the corner after two years of losing ground to competitors. Schizophrenia treatment Zyprexa, under fire from eight states and thousands of patients, continues to eke out small sales gains.
From: www.indystar.com
Lilly profit impresses Wall Street
Posted by Ruslan Abuzant at 12:32 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment